Caladrius Biosciences, Inc. (CLBS) Social Stream



Caladrius Biosciences, Inc. (CLBS): $6.40

-1.26 (-16.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLBS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 449

in industry

CALADRIUS BIOSCIENCES INC (CLBS) Price Targets From Analysts

Use the tables below to see what analysts covering CALADRIUS BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 2 $10 $8 $9 $0.493 1725.56%
2022-05-24 3 $10 $6 $8 $0.493 1522.72%
2022-08-05 3 $6 $3 $4.5 $0.493 812.78%

The Trend in the Analyst Price Target


Over the past 18 months, CLBS's average price target has gone down $4.5.

Over the past 48 weeks, CLBS's average upside potential has been 932.23%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 4 10 10 10.0 1.240 706.45%
2021-09-18 3 10 10 10.0 1.200 733.33%
2022-04-27 3 10 6 8.0 0.610 1211.48%
2022-05-06 3 10 6 8.0 0.466 1616.74%
2022-05-24 3 6 3 4.5 0.460 878.26%

CLBS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 29 months, CLBS's average broker recommendation rating worsened by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CLBS as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, CALADRIUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 393.3% of them.
  • CALADRIUS BIOSCIENCES INC's average analyst price target is greater than 27.25% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, CALADRIUS BIOSCIENCES INC's number of analysts covering the stock is higher than 26.38% of them.
  • CLBS has a lower variance in analysts' estimates than -40.51% of Healthcare stocks.

In the Healthcare industry, BXRX, PMD, and OPGN are the three stocks most similar to CALADRIUS BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

Is CLBS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6934 seconds.